Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression.
about
The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic ReviewFuture Directions for Pharmacotherapies for Treatment-resistant Bipolar DisorderNew developments in the management of schizophrenia and bipolar disorder: potential use of cariprazineUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismDopamine receptors - IUPHAR Review 13Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsAripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity.Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands.
P2860
Q26748677-3648D73B-FFB9-427F-BEA2-3C54F71F1476Q26782989-6093000D-1670-4148-8B6C-6DCE99CC308DQ28083061-26BF1CDF-D20E-4733-B4DD-6242D4665A11Q28084069-BD550DB0-46AB-40A4-9BB8-17AF108B12BDQ28256783-D462BA8E-57FB-47F1-9409-87DE1A575EECQ30249553-84353591-0EF9-4E1C-9CDA-61D0FF8F693DQ35892818-77258E12-A93E-477D-A12C-20813D2FE441Q37197216-4AD281D3-D69A-47BB-ADD0-D78BF7758035Q39244947-7171F1A1-3605-4B31-AEDA-C18C5ACA411DQ42141320-962696CC-3A2B-4E4E-B456-DC1D2924775FQ53750464-4A55E2E6-0963-4F2B-9F07-961F4EECAF71
P2860
Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cariprazine, a new, orally act ...... bipolar mania and depression.
@ast
Cariprazine, a new, orally act ...... bipolar mania and depression.
@en
Cariprazine, a new, orally act ...... bipolar mania and depression.
@nl
type
label
Cariprazine, a new, orally act ...... bipolar mania and depression.
@ast
Cariprazine, a new, orally act ...... bipolar mania and depression.
@en
Cariprazine, a new, orally act ...... bipolar mania and depression.
@nl
prefLabel
Cariprazine, a new, orally act ...... bipolar mania and depression.
@ast
Cariprazine, a new, orally act ...... bipolar mania and depression.
@en
Cariprazine, a new, orally act ...... bipolar mania and depression.
@nl
P2860
P1476
Cariprazine, a new, orally act ...... bipolar mania and depression.
@en
P2093
Gerhard Gründer
Tanja Veselinović
P2860
P304
P356
10.1586/14737175.2013.853448
P577
2013-11-01T00:00:00Z